
Thursday, October 31, 2024 5:55:02 PM
Anyway I see that the NCT number is NCT03360214
https://www.clinicaltrials.gov/study/NCT03360214?tab=history&a=7#version-content-panel
Underpowered trial. Results make it look like the PEMF placebo group had less pain than the Active PEMF group.
Same thing happened to Ilfeld in his ActiPatch opioid study. Underpowered trial. Results make it look like the PEMF placebo group had less pain than the Active PEMF group.
Disclaimer: I'm not buying BIEL or ENDV. I just like doing the DD.
Recent ENDV News
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 09/19/2024 07:00:01 PM
Basanite Industries, Inc. Appoints Michael D. Nelson as Chief Executive Officer • BASA • Mar 21, 2025 9:01 AM
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • FITY • Mar 20, 2025 9:00 AM
VAYK Forms Partnership with Airbnb Investing Group to Offer Service Solution • VAYK • Mar 20, 2025 9:00 AM
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger • CATV • Mar 20, 2025 8:30 AM
NUBURU Announces Elimination of 100% of its Long-Term Indebtedness and $5.15 Million Strategic Investment in Supply@ME Capital • BURU • Mar 19, 2025 8:53 AM
Authentic Holdings, Inc. to Acquire Movie and Television Library in an $11 Million Transaction • AHRO • Mar 19, 2025 8:30 AM